Navigation Links
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
Date:5/7/2009

ABBOTT PARK, Ill., May 7 /PRNewswire-FirstCall/ -- The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH).

This recommendation was made by the Cross-Network Laboratory Focus Group (LFG), which consists of representatives from five of the NIH-sponsored HIV/AIDS clinical trials networks. The LFG recently issued a consensus statement, which was reviewed and approved by the leadership of the five networks, recommending the use of the Abbott RealTime HIV-1 assay and m2000 system for upcoming clinical trials in 2009 and beyond that have a primary focus on viral load measurements. The recommendation applies to testing performed at adult and pediatric therapeutic HIV/AIDS clinical trial sites both in the United States and internationally, as well as the centralized network laboratories in the United States.

Viral load testing is a monitoring tool used to determine the amount of virus in the blood and the efficacy of anti-HIV therapy. The growing prevalence of HIV-1 subtype variant and circulating recombinant strains has made accurate viral load detection more complex and has prompted increasing numbers of clinical laboratories to adopt the Abbott RealTime HIV-1 Assay on the m2000 System. The system is one of the fastest and most sensitive viral load tests available, with the ability to detect and precisely measure group M, N and O strains of HIV-1, as well as all known non-B subtypes.

"We're pleased that the LFG has recommended the Abbott RealTime HIV viral load assay to be the standard testing system for NIH-sponsored HIV/AIDS clinical trial networks," said Stafford O'Kelly, head of Abbott's molecular diagnostics business. "We look forward to supporting the NIH-sp
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
2. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
3. German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
4. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
5. Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees
6. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
7. NCPS Outraged at HIV/AIDS Medi-Cal Cuts
8. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
9. Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Intarcia Therapeutics, Inc. today announced ... recently announced synthetic royalty / equity convert financing, bringing ... purchased Convertible Limited Recourse Notes from Intarcia and are ... any future global net sales of ITCA 650 until ... have the option, commencing upon U.S. regulatory approval of ...
(Date:6/2/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... U.S. Food and Drug Administration (FDA) of its Abbreviated ... 5mg/5mL. Trailing twelve-month sales for the product are $30 ... expects to begin shipping to its customers shortly. ... of ANI Pharmaceuticals, stated, "This ANDA represents ANI,s first ...
(Date:6/2/2015)... 2, 2015  PROMETRIKA, LLC, a full-service clinical ... the addition of pharmacovigilance services for clinical trials.  ... safety data collection and reporting, as our service ... and expert physicians, each with more than 23 years ... monitoring of safety trends. ...
Breaking Medicine Technology:Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3PROMETRIKA Announces the Availability of Pharmacovigilance Services 2
... SAN DIEGO, July 9 Arena Pharmaceuticals, ... results from a multiple-ascending,dose Phase 1b clinical ... safety,pharmacokinetics and pharmacodynamics. APD791 is Arena,s internally,discovered ... of arterial,thrombosis and other related conditions., ...
... July 8 After meeting on July 1st ... new diabetes drugs should,undergo trials to rule out ... US endocrinologists agree with this recommendation, according to,AlphaDetail ... market,research and key opinion leader mapping solutions to ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2
(Date:6/2/2015)... Allred Dental, a dental office based in ... June-September, 2015 along with a $100 off with free oral ... , “Sometimes wisdom teeth can be impacted, meaning that they ... also only partially break through the gum, causing pain and ... in young people, as they do not have fully developed ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
(Date:6/2/2015)... Los Angeles, CA (PRWEB) June 02, 2015 ... "100K Factory" system was released to public yesterday, ... around the Internet. HonestyFirstReviews.com's senior product reviewer Tiffany ... posting a detailed review of the course on ... of training courses available for Internet marketers looking ...
(Date:6/2/2015)... 2015 MEDIA ADVISORY, June 2, ... , Email: ewallace(at)mentalhealthamerica(dot)net , Breaking News: Congressman Tim ... Legislation at MHA Annual Conference Thursday , Who: ... to address the Mental Health America Annual Conference ... version of the Helping Families in Mental Health ...
(Date:6/2/2015)... MI (PRWEB) June 02, 2015 On ... “Fighting Addiction Together” in the Hall of Legends at ... receiver and motivational speaker Herman Moore, the goal of ... of addiction in today’s society, highlight the benefits of ... inform the attendees about the options that are available ...
Breaking Medicine News(10 mins):Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2
... LOS ANGELES, Dec. 15 The holidays will be ... Southern California,s,largest children,s hospitals thanks to supermarket partners Ralphs ... The two supermarket chains announced today that they ... in communities served by their,stores in Southern California. The ...
... Dec. 15 The American Academy of,Dermatology (Academy) today issued ... to Congress about labeling information on the,relationship between the use ... skin damage. The FDA report was submitted pursuant to ... 2007. , "The American ...
... under age 65 were without health insurance for all or ... by the UCLA Center for Health Policy Research. ... California Health Interview Survey (CHIS), the policy brief,s authors found ... all or some of 2007, the most recent year for ...
... Aurora Health Care announced today that,the physicians of ... Wisconsin, have chosen to join Aurora Medical Group. , ... practice chiefly at Aurora hospitals and,clinics. , ... contribute to the quality,of the care we provide for Aurora ...
... from Medarex,s UltiMAb(R) technology platform - , ... (Nasdaq: MEDX ) today announced that it will ... in connection with the recently announced marketing approval from Health ... (ustekinumab, previously known as CNTO 1275) for ...
... lead people to choose salads over French fries? According to ... , people who choose from a large variety of menu ... who choose from shorter lists. , In a study that ... authors Aner Sela (Stanford University), Jonah Berger (University of Pennsylvania), ...
Cached Medicine News:Health News:Southern California Children's Hospitals to Receive $125,000 Holiday Gift From Ralphs and Food 4 Less 2Health News:American Academy of Dermatology Issues Statement on FDA Report to Congress About Labeling Information on Indoor Tanning Devices 2Health News:Nearly 6.4 million Californians lack health insurance, report shows 2Health News:Great Lakes Radiologists to Join Aurora Medical Group 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 3Health News:The virtue of variety: More options can lead to healthier choices 2
... a low-price PC-based, 2-8-channel system for ... the retina and the optic nerve. ... operator monitor, printer, keyboard, mouse, bioelectrical ... electrical connections are easily to install. ...
... tool that allows to see the fundus ... stimulated. Besides it also includes the refractive ... between the pupil picture and the fundus ... is especially suited for animal research and ...
5 mm...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
Medicine Products: